BIOQUÍMICA Y BIOLOGÍA MOLECULAR I
Departamento
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (19)
2023
2021
-
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival
International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894
-
Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium
Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17
2020
-
Polymorphisms within the ARNT2 and CX3CR1 genes are associated with the risk of developing invasive aspergillosis
Infection and Immunity, Vol. 88, Núm. 4
2017
-
Identification of miRSNPs associated with the risk of multiple myeloma
International Journal of Cancer, Vol. 140, Núm. 3, pp. 526-534
2016
-
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis
Oncotarget, Vol. 7, Núm. 37, pp. 59029-59048
-
Common genetic polymorphisms within NFκB-related genes and the risk of developing invasive aspergillosis
Frontiers in Microbiology, Vol. 7, Núm. AUG
-
Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients
American Journal of Hematology, Vol. 91, Núm. 7, pp. 700-704
-
Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: Results from the AspBIOmics Consortium
Infection and Immunity, Vol. 84, Núm. 3, pp. 643-657
2015
-
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients
Nature Communications, Vol. 6
-
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length
International Journal of Cancer, Vol. 136, Núm. 5, pp. E351-E358
-
Type 2 diabetes-related variantsinfluence the risk of developing multiple myeloma: Results from the IMMEnSE consortium
Endocrine-Related Cancer, Vol. 22, Núm. 4, pp. 545-559
2014
-
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations - An extensive replication of the associations from the candidate gene era
Cancer Epidemiology Biomarkers and Prevention, Vol. 23, Núm. 4, pp. 670-674
2010
-
Are elite endurance athletes genetically predisposed to lower disease risk?
Physiological Genomics, Vol. 41, Núm. 1, pp. 82-90
-
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Nature Genetics, Vol. 42, Núm. 5, pp. 426-429
2008
-
Expression signatures in lung cancer reveal a profile for EGFR-mutant tumours and identify selective PIK3CA overexpression by gene amplification
Journal of Pathology, Vol. 214, Núm. 3, pp. 347-356
2007
-
Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer
Oncogene, Vol. 26, Núm. 11, pp. 1616-1625
2006
-
DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy
Journal of Clinical Oncology, Vol. 24, Núm. 26, pp. 4333-4339
2005
-
Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells
Human Molecular Genetics, Vol. 14, Núm. 7, pp. 973-982